VIH / SIDA
El cannabis ha demostrado potencial para mejorar la calidad de vida de las personas que viven con VIH/SIDA al abordar varios síntomas asociados. Los cannabinoides, en particular el tetrahidrocannabinol (THC) y el cannabidiol (CBD), han demostrado aliviar el dolor crónico, reducir la inflamación y estimular el apetito, abordando problemas significativos como el síndrome de desgaste y el dolor neuropático que suelen experimentar los pacientes (Abrams et al., 2007).
Los estudios revelan que el cannabis puede aumentar el apetito al activar los receptores CB1 en el cerebro, ayudando a combatir la pérdida severa de peso y la desnutrición, que son complicaciones comunes del VIH/SIDA (Haney et al., 2005).
Además, sus propiedades analgésicas proporcionan alivio del dolor neuropático, un síntoma debilitante del daño nervioso relacionado con el VIH (Ellis et al., 2009).
El cannabis también puede contribuir al bienestar mental al reducir la ansiedad, la depresión y los niveles de estrés, que son prevalentes entre las personas que manejan una condición crónica como el VIH/SIDA (Beck & McKenna, 2016). Aunque el cannabis no puede curar el VIH/SIDA, ofrece una terapia complementaria eficaz para el manejo de los síntomas y la mejora del confort general y la funcionalidad en la vida diaria. La investigación en curso busca optimizar su uso, garantizando al mismo tiempo la seguridad y la eficacia en esta población vulnerable.
References
- 1. Abrams, D. I., Hilton, J. F., Leiser, R. J., et al. (2007). Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Annals of Internal Medicine, 139(4), 258-266.
- 2. Haney, M., Gunderson, E. W., Rabkin, J., et al. (2005). Dronabinol and marijuana in HIV-positive marijuana smokers. Journal of Pain and Symptom Management, 29(4), 297-306.
- 3. Ellis, R. J., Toperoff, W., Vaida, F., et al. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology, 34(3), 672-680.
- 4. Beck, A., & McKenna, M. (2016). Cannabis as a therapeutic agent for HIV/AIDS-related conditions. Canadian Journal of Infectious Diseases and Medical Microbiology, 27(1), 1-7.
- 5. Prentiss, D., Power, R., Balmas, G., et al. (2004). Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. Journal of Acquired Immune Deficiency Syndromes, 35(1), 38-45.
Servicios relacionados
Cannabis has garnered attention as a potential adjunct therapy for bipolar disorder, offering therapeutic benefits when used…
Cannabis has emerged as a complementary option in managing cancer-related symptoms, providing…
Cannabis has shown promise as a therapeutic option for managing Crohn’s disease, a chronic…
Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief…
Cannabis is being explored as a potential adjunct therapy for managing depression, offering…
Cannabis, particularly cannabidiol (CBD) has shown significant promise in managing epilepsy,…
Cannabis has been explored as a potential treatment for glaucoma, a condition characterized…
Cannabis is being studied as a potential therapy for managing pain associated with gout, a form of…
Cannabis is being explored as a complementary therapy for managing symptoms associated with….
Cannabis has been studied for its potential to help manage hypertension (high blood pressure), a…
Cannabis has gained as a potential treatment for Irritable Bowel Syndrome (IBS), a gastrointestinal disorder…
Cannabis has gained attention as a potential treatment for insomnia, a common sleep disorder..
Cannabis has shown potential in the treatment of migraines, a neurological condition characterized…
Cannabis has shown potential as a therapeutic option for managing symptons of multiple sclerosis (MS), a chronic…